Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization.

Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization.

Item
http://www.wikidata.org/entity/Q33368859
Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients.Partial splenic embolization.Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy.A retrospective cohort study of partial splenic embolization for antiviral therapy in chronic hepatitis C with thrombocytopenia.Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet countsPartial Splenic Embolization as a Bridge to Total Knee Replacement for a Patient with Severe Thrombocytopenia due to Cirrhosis and Splenic Sequestration.Large splenic volume may be a useful predictor for partial splenic embolization-induced liver functional improvement in cirrhotic patients.Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C.Management of thrombocytopenia due to liver cirrhosis: a reviewPartial splenic artery embolization in cirrhotic patientsEffect of spleen operation on antiviral treatment in hepatitis C virus-related cirrhotic patients.JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2.Pegylated interferon α-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose.Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count.Very-Low-Dose Pegylated Interferon a2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention.Guidelines for the Management of Hepatitis C Virus Infection: First edition, May 2012, The Japan Society of Hepatology.Correcting thrombocytopenia in patients with liver diseases: a difficult hurdle.
P2860

Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization.

Item
http://www.wikidata.org/entity/Q33368859
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Safe use of pegylated interfer ...... partial splenic embolization.
@ast
Safe use of pegylated interfer ...... partial splenic embolization.
@en
type
label
Safe use of pegylated interfer ...... partial splenic embolization.
@ast
Safe use of pegylated interfer ...... partial splenic embolization.
@en
prefLabel
Safe use of pegylated interfer ...... partial splenic embolization.
@ast
Safe use of pegylated interfer ...... partial splenic embolization.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Safe use of pegylated interfer ...... partial splenic embolization.
@en
P2093
P304
P31
P356
10.1097/00042737-200511000-00002
P433
P478
P50
P577
P698
P921